1,1-diethoxy-4-methyl-pentan-3-one | 31086-95-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1,1-diethoxy-4-methyl-pentan-3-one
• 英文别名: 4-methyl-3-oxo-valeraldehyde diethylacetal；4-Methyl-3-oxo-valeraldehyd-diaethylacetal；1,1-Diaethoxy-4-methyl-pentan-3-on；1,1-Diethoxy-4-methylpentan-3-one
• CAS: 31086-95-0
• 化学式: C₁₀H₂₀O₃
• 分子量: 188.267
• InChiKey: KOIPMSUHGXNNLY-UHFFFAOYSA-N

物化性质

• 沸点：
  86-87 °C(Press: 11 Torr)
• 密度：
  0.9229 g/cm3(Temp: 420 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1,1-diethoxy-4-methyl-pentan-3-one 在 哌啶 、 盐酸 、 水 、 溶剂黄146 作用下， 生成 6-异丙基-2-氧代-1,2-二氢-吡啶-3-羧酸
  参考文献：
  名称：

  Kotschetkow, Doklady Akademii Nauk SSSR, 1952, vol. 84, p. 289,292

  摘要：

  DOI：
• 作为产物：
  描述：

  (E)-isopropyl 2-chlorovinyl ketone 、 乙醇 在 氢氧化钾 作用下， 生成 1,1-diethoxy-4-methyl-pentan-3-one
  参考文献：
  名称：

  Kotschetkow, Doklady Akademii Nauk SSSR, 1952, vol. 84, p. 289,292

  摘要：

  DOI：

文献信息

• 3-Phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
  申请人：——

  公开号：US20030176449A1

  公开（公告）日：2003-09-18

  A class of 3-phenylimidazo(1,2-&agr;) pyrimidine derivatives (of Formula I, or salt or prodrug thereof: I) wherein Y represents a chemical bond, an oxygen atom, or a —NH— linkage; Z represents an optionally substituted aryl or heteroaryl group; R 1 represents hydrogen, hydrocarbon, a heterocyclic group, halogen, cyano trifluoromethyl, nitro, —OR a , —SR a , —SOR a , —SO 2 R a , —SO 2 NR a R b , —NR a R b , —NR a COR b , —NR a CO 2 R b , —COR a , CO 2 R a , —CONR a R b or —CR a ═NOR b ; and R a and R b independently represent hydrogen, hydrocarbon or a heterocyclic group.), substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, are selective ligands for GABA A receptors, in particular having good affinity for the a2 and/or a3 and/or a5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders. 1

  一类3-苯基咪唑[1,2-a]嘧啶衍生物（化学式I，或其盐或前药：I），其中Y代表化学键，氧原子，或—NH—连接；Z代表可选择取代的芳基或杂芳基团；R1代表氢，碳氢化合物，杂环基团，卤素，氰基，三氟甲基，硝基，—ORa，—SRa，—SORa，—SO2Ra，—SO2NRaRb，—NRaRb，—NRaCORb，—NRaCO2Rb，—CORa，CO2Ra，—CONRaRb或—CRa═NORb；而Ra和Rb独立地代表氢，碳氢化合物或杂环基团，取代苯环的间位由一个可选择取代的芳基或杂芳基团取代，该芳基或杂芳基团直接连接或通过氧原子或—NH—连接桥接，是GABAA受体的选择性配体，特别对a2和/或a3和/或a5亚基具有良好的亲和力，因此对于治疗和/或预防中枢神经系统的不良症状，包括焦虑、抽搐和认知障碍具有益处。
• [EN] IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS<br/>[FR] DERIVES D'IMIDAZO-PYRIMIDINE COMME LIGANDS POUR LES RECEPTEURS GABA
  申请人：MERCK SHARP & DOHME

  公开号：WO2002074773A1

  公开（公告）日：2002-09-26

  A class of 3-phenylimidazo[1,2-a]pyrimidine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a -NH- linkage, and further substituted on the phenyl ring by alkyl, trifluoromethyl, alkoxy or one or two halogen atoms, especially fluoro, are selective ligands for GABAA receptors, in particular having good affinity for the a2 and/or a3 and/or a5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类3-苯基咪唑并[1,2-a]嘧啶衍生物，苯环的间位被取代为可选择取代的芳基或杂环基，该基团直接连接或通过氧原子或-NH-键桥接，并且苯环上进一步取代为烷基，三氟甲基，烷氧基或一个或两个卤素原子，特别是氟原子。这些化合物是GABAA受体的选择性配体，特别是对其中的a2和/或a3和/或a5亚基具有良好的亲和力，因此有助于治疗和/或预防中枢神经系统的不良症状，包括焦虑，抽搐和认知障碍。
• Imidazo-pyrimidine derivatives as ligands for gaba receptors
  申请人：——

  公开号：US20020193385A1

  公开（公告）日：2002-12-19

  A class of 3-phenylimidazo[1,2-&agr;]pyrimidine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, and further substituted on the phenyl ring by alkyl, trifluoromethyl, alkoxy or one or two halogen atoms, especially fluoro, are selective ligands for GABA A receptors, in particular having good affinity for the &agr;2 and/or &agr;3 and/or &agr;5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类3-苯基咪唑[1,2-&agr;]嘧啶衍生物，苯环的间位被取代，取代基可以是直接连接或通过氧原子或-NH-键桥接的取代芳基或杂环芳基，苯环上进一步被取代为烷基，三氟甲基，烷氧基或一个或两个卤素原子，特别是氟，是GABAA受体的选择性配体，特别是对其中的&agr;2和/或&agr;3和/或&agr;5亚基具有良好的亲和力，因此对于治疗和/或预防中枢神经系统的不良症状，包括焦虑，惊厥和认知障碍具有益处。
• 3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors
  申请人：Merck Sharp & Dohme Ltd.

  公开号：US06642229B2

  公开（公告）日：2003-11-04

  A class of 3-phenylimidazo(1,2-a)pyrimidine derivatives (of Formula I, or salt or prodrug thereof: I) wherein Y represents a chemical bond, an oxygen atom, or a —NH— linkage; Z represents an optionally substituted aryl or heteroaryl group; R1 represents hydrogen, hydrocarbon, a heterocyclic group, halogen, cyano trifluoromethyl, nitro, —ORa, —SRa, —SORa, —SO2Ra, —SO2NRaRb, —NRaRb, —NRaCORb, —NRaCO2Rb, —CORa, CO2Ra, —CONRaRb or —CRa═NORb; and Ra and Rb independently represent hydrogen, hydrocarbon or a heterocyclic group.), substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, are selective ligands for GABAA receptors, in particular having good affinity for the a2 and/or a3 and/or a5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类3-苯基咪唑并[1,2-a]嘧啶衍生物（化学式I，或其盐或前药：I），其中Y代表化学键，氧原子或—NH—连接；Z代表可选取代的芳基或杂芳基基团；R1代表氢、碳氢化合物、杂环基团、卤素、氰、三氟甲基、硝基、—ORa、—SRa、—SORa、—SO2Ra、—SO2NRaRb、—NRaRb、—NRaCORb、—NRaCO2Rb、—CORa、CO2Ra、—CONRaRb或—CRa═NORb；而Ra和Rb分别独立地代表氢、碳氢化合物或杂环基团。这些衍生物在苯环的间位上取代了可选取代的芳基或杂芳基基团，该基团直接连接或通过氧原子或—NH—连接桥接，是GABAA受体的选择性配体，特别是对a2和/或a3和/或a5亚单位具有良好的亲和力，因此对于治疗和/或预防中枢神经系统的不良症状，包括焦虑、惊厥和认知障碍，具有益处。
• 3-PHENYL-IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS
  申请人：MERCK SHARP & DOHME LTD.

  公开号：EP1294723A1

  公开（公告）日：2003-03-26